These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8893678)

  • 1. Biologic effects of 17 alpha-dihydroequilin sulfate.
    Wilcox JG; Stanczyk FZ; Morris RS; Gentzschein E; Lobo RA
    Fertil Steril; 1996 Nov; 66(5):748-52. PubMed ID: 8893678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic effects of delta-8-estrone sulfate in postmenopausal women.
    Bhavnani BR; Cecutti A; Dey MS
    J Soc Gynecol Investig; 1998; 5(3):156-60. PubMed ID: 9614646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic effects of equilin sulfate in postmenopausal women.
    Lobo RA; Nguyen HN; Eggena P; Brenner PF
    Fertil Steril; 1988 Feb; 49(2):234-8. PubMed ID: 3338581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of equine estrogens: binding of conjugated and unconjugated equine estrogens with human serum proteins.
    Pan CC; Woolever CA; Bhavnani BR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):499-507. PubMed ID: 4040531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein.
    Wilcox JG; Hwang J; Hodis HN; Sevanian A; Stanczyk FZ; Lobo RA
    Fertil Steril; 1997 Jan; 67(1):57-62. PubMed ID: 8986684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of [3H] 17 beta-dihydroequilin and [3H] 17 beta-dihydroequilin sulfate in normal postmenopausal women.
    Bhavnani BR; Cecutti A; Wallace D
    Steroids; 1994 Jun; 59(6):389-94. PubMed ID: 7940618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 17 beta-dihydroequilin sulfate and 17 beta-dihydroequilin in normal postmenopausal women.
    Bhavnani BR; Cecutti A
    J Clin Endocrinol Metab; 1994 Jan; 78(1):197-204. PubMed ID: 8288704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 17 beta-dihydroequilin sulfate in normal postmenopausal women under steady state conditions.
    Bhavnani BR; Cecutti A; Gerulath A
    J Soc Gynecol Investig; 2002; 9(2):102-10. PubMed ID: 12398033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine estrogens differentially prevent neuronal cell death induced by glutamate.
    Bhavnani BR; Berco M; Binkley J
    J Soc Gynecol Investig; 2003 Jul; 10(5):302-8. PubMed ID: 12853093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of equilin sulfate in the dog.
    Chandrasekaran A; Osman M; Scatina JA; Sisenwine SF
    J Steroid Biochem Mol Biol; 1995 Nov; 55(2):271-8. PubMed ID: 7495708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
    Goebelsmann U; Mashchak CA; Mishell DR
    Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic clearance rate of equilin sulfate and its conversion to plasma equilin, conjugated and unconjugated equilenin, 17 beta-dihydroequilin, and 17 beta-dihydroequilenin in normal postmenopausal women and men under steady state conditions.
    Bhavnani BR; Cecutti A
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1269-74. PubMed ID: 8077320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conjugated equine estrogen with differential effects on uterine weight and plasma cholesterol in the rat.
    Washburn SA; Adams MR; Clarkson TB; Adelman SJ
    Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):251-4; discussion 254-6. PubMed ID: 8395768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women.
    Longcope C; Herbert PN; McKinlay SM; Goldfield SR
    J Clin Endocrinol Metab; 1990 Jul; 71(1):67-72. PubMed ID: 2115047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen activity and novel tissue selectivity of delta8,9-dehydroestrone sulfate in postmenopausal women.
    Baracat E; Haidar M; Lopez FJ; Pickar J; Dey M; Negro-Vilar A
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2020-7. PubMed ID: 10372704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipid profile improved by ultra-low doses of 17 beta-estradiol in elderly women.
    Naessen T; Rodriguez-Macias K; Lithell H
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2757-62. PubMed ID: 11397883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of serum lipids and cardiovascular risk by estrogenic active compounds.
    Windler E
    Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():21-8. PubMed ID: 10862265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors.
    Wilcox JG; Hatch IE; Gentzschein E; Stanczyk FZ; Lobo RA
    Fertil Steril; 1997 Feb; 67(2):273-7. PubMed ID: 9022602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes.
    Lobo RA; March CM; Goebelsmann U; Krauss RM; Mishell DR
    Am J Obstet Gynecol; 1980 Nov; 138(6):714-9. PubMed ID: 6776814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR; Kraemer RR; Ogden BW; Kilpatrick RE; Gimpel TL; Castracane VD
    Fertil Steril; 2003 Mar; 79(3):534-42. PubMed ID: 12620436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.